All In Biotech

Drug Trial Radar · NCT07915024

Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants

A Single-Center, Randomized, Double-Blind, Placebo-Controlled and Active-Controlled (Open-Label) Phase I Clinical Trial to Evaluate the Effect of Single Oral Administration of HSK31858 Tablets on QTc Interval in Healthy Chinese Participants

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

47

Planned (sponsor's estimate)

Start

Aug 6, 2026

Primary completion

Nov 2026

Study completion Jan 2027

Sponsor

Sponsor type
Industry
First posted
Nov 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a concentration-QTc interval clinical study of HSK31858 tablets in healthy participants.

Conditions

  • Non-cystic Fibrosis Bronchiectasis (NCFBE)

Interventions

  • HSK31858 tabletDrug

    oral

  • PlaceboDrug

    oral

  • MoxifloxacinDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes of QTc intervalTime frame: Baseline, Day14, Day28

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)

    Jinan, Shandong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.